Warning: Creating default object from empty value in /web/htdocs/www.eamas.net/home/CzetaFrameWork/index.php on line 35
EAMAS - Associazione Europea amici della Sindrome di McCune-Albright

EAMAS - Associazione Europea amici della Sindrome di McCune-Albright

European Association Friends of Mc Cune Albright Syndrome

Scegli la lingua:
IT EN FR DE ES

Contatta EAMAS


Home

Che cos'è EAMAS
Patologie trattate
Esperienze personali
Medici e ospedali
Glossario
Pubblicazioni
Link utili
Novità dell'associazione
Conferenze e simposi
Come finanziare EAMAS

Sponsor dell'anno

Ultimo aggiornamento:
12/12/2019

Best view 1024 x 768
Ottimizzato per IE



 

 

Pubblicazioni

Elenco completo

Elenco completo

PATOLOGIA: LINGUA:  
ARGOMENTO: TESTO:
TITOLOAUTORIEDITOREANNODOSSIERPAGINELINGUA
Bisphosphonates: pharmacology, mechenism of action and clinical usesRussel RG, Croucher PI, Rogers MJ,Osteoporosis Int19999 (Suppl 2)S66en
A new constitutively activating mutation of the G, protein alpha subunit-gsp oncogene is found in human pituitary tumoursClementi E, Malgaretti N, Meldolesi J, Taramelli R,Oncogene199051059-1061en
Direct measurement of TP/GFR: a simple and reliable parameter of renal phophate handlingStark H, Eisenstein B, Tieder M, Rachmel A, Alpert G,Nephron198644125-128en
The GTPase superfamily: a conserved switch for diverse cell functionsBourne HR, Sanders DA, McCormick F,Nature1990348125-132en
GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumoursLandis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L,Nature1989340692-696en
Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomasVallar L, Spada A, Giannattasio G,Nature1987330566-567en
Activating mutations of the stimulatory G protein in the McCune-Albright syndromeWeinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM,N Engl J Med19913251688-1695en
Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactoneFeuillan PP, Foster CM, Pescovitz OH, Hench KD, Shawker T, Dwyer A, Malley JD, Barnes K, Loriaux DL, Cutler GB Jr,N Engl J Med19863151115-1119en
Failure of disodium etidronate in calcinosis due to dermatomyositis and sclerodermaMetzger AL, Singer FR, Bluestone R, Pearson CM,N Engl J Med19742911294-1296en
Cyclic administration of pamidronate in children with severe osteogenesis imperfectaGlorieux FH, Bishop NJ, Plotikin H, Chabot G, Lanoue G, Travers R,N Engl J Med1998339947-952en
Short-term effects of pamidronate in patients with Gaucher's disease and severe skeletal involvement [Letter]Ciani G, Cuttini M, Bembi B,N Engl J Med1997337712en
Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. Report of five casesAlbright F, Butler AM, Hampton AO, Smith P,N Engl J Med1937216727-746en
An animal model of fibrous dysplasiaBianco P, Robey PG,Mol Med Today19995322-323en
Activating and inactivating mutations in LH receptorsThemmen AP, Martens JW, Brunner HG,Mol Cell Endocrinol1998145137-142en
Functional and clinical consequences of mutations in the FSH receptorGromoll J, Simoni M, Nordhoff V, Behre HM, De Geyter C, Nieschlag E,Mol Cell Endocrinol1996125177-182en
Fibrodysplasia ossificans. Presentation of a case of exceptional severityCottafava F, Nieri S, Racugno A, Corciulo P, Prestandrea C, Brida di Prio S, Villa Venzano G, Pinelli G,Minerva Pediatr19863853-58en
Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophyRingel MD, Schwindinger WF, Levine MA,Medicine (Baltimore)199675171-184en
Use of pamidronate in the management of acute cancer-related hypercalcaemia in childrenYoung G, Shende A,Med Pediatr Oncol199830117-121en
Wirkung von Pamidronat auf Bescwerdebild und Knochenstoffwechsel bei fibroser Dysplasie und McCune-Albright-SyndromPfeilschifter J, Ziegler R,Med Klin199893352-359de
Regression of bone lesions in Gaucher's disease during treatment with aminohydroxyproylidene bisphosphonate [Letter]Harinck HI, Bijvoet OL, van der Meer JW, Jones B, Onvlee GJ,Lancet1984ii513en

Righe 20 di 186
Pagine: [ 1 ] [  2  ] [ 3 ] [ 4 ] [ 5 ] [ 6 ] [ 7 ] [ 8 ] [ 9 ] [ 10 ] 

 


Login:
Password:


Non hai una password?
REGISTRATI

Scordato la password?
Perchè iscriversi?
Consigli di utilizzo


Contatta EAMAS
Associarsi ad EAMAS
Contatta il web master


EAMAS - Associazione Europea amici della Sindrome di McCune-Albright
Via Borgovecchio, 25 - 10041 Carignano (TO) - Italy - Tel:+39 011-9697258 - Fax:+39 011-9697258